Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Invested Capital: 2020-2023

Historic Invested Capital for Candel Therapeutics (CADL) over the last 3 years, with Sep 2023 value amounting to $29.1 million.

  • Candel Therapeutics' Invested Capital fell 59.62% to $29.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $29.1 million, marking a year-over-year decrease of 59.62%. This contributed to the annual value of $67.7 million for FY2022, which is 4.66% up from last year.
  • Latest data reveals that Candel Therapeutics reported Invested Capital of $29.1 million as of Q3 2023, which was down 15.40% from $34.4 million recorded in Q2 2023.
  • Candel Therapeutics' 5-year Invested Capital high stood at $83.8 million for Q1 2022, and its period low was -$42.7 million during Q2 2021.
  • Moreover, its 3-year median value for Invested Capital was $64.1 million (2021), whereas its average is $49.4 million.
  • Per our database at Business Quant, Candel Therapeutics' Invested Capital spiked by 380.33% in 2021 and then crashed by 59.62% in 2023.
  • Over the past 4 years, Candel Therapeutics' Invested Capital (Quarterly) stood at -$23.1 million in 2020, then spiked by 380.33% to $64.7 million in 2021, then increased by 4.66% to $67.7 million in 2022, then tumbled by 59.62% to $29.1 million in 2023.
  • Its Invested Capital stands at $29.1 million for Q3 2023, versus $34.4 million for Q2 2023 and $40.9 million for Q1 2023.